Clinical Trial: Terlipressin Administration in Septic Shock Refractory to Catecholamines

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Terlipressin Administration in Septic Shock Refractory to Catecholamines Bolus vs. Continuous Drip-Phase II

Brief Summary: terlipressin is given to refractory septic shock patients who do not respond to noradrenalin in Israel and Europe. It is given by bolus injection. we attempt to investigate weather it is better to give it by continuous drip and avoid abrupt changes in BP and heart function

Detailed Summary:
Sponsor: Assaf-Harofeh Medical Center

Current Primary Outcome: CI, SVR,HR,BP, noradrenalin administration,renal function [ Time Frame: 6 mo ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Assaf-Harofeh Medical Center

Dates:
Date Received: November 18, 2008
Date Started: November 2008
Date Completion: July 2009
Last Updated: November 18, 2008
Last Verified: November 2008